FDA-Drafted Folic Acid Health Claim Disclaimers Ordered By Federal Judge
This article was originally published in The Tan Sheet
Executive Summary
FDA must draft "one or more appropriately short, succinct and accurate disclaimers" to accompany the Pearson plaintiffs' proposed dietary supplement health claim for folic acid/neural tube defects, a Washington, D.C. judge ruled Feb. 1 in a firmly worded opinion.
You may also be interested in...
FDA Antioxidants Claim Review Improperly Focused On Prevention - Lawsuit
FDA inappropriately focused on cancer-prevention evidence in denying a proposed dietary supplement health claim for antioxidant vitamins and cancer risk reduction, supplement firms say in a lawsuit filed against the agency July 16.
FDA Antioxidants Claim Review Improperly Focused On Prevention - Lawsuit
FDA inappropriately focused on cancer-prevention evidence in denying a proposed dietary supplement health claim for antioxidant vitamins and cancer risk reduction, supplement firms say in a lawsuit filed against the agency July 16.
FDA Antioxidants Claim Review Improperly Focused On Prevention - Lawsuit
FDA inappropriately focused on cancer-prevention evidence in denying a proposed dietary supplement health claim for antioxidant vitamins and cancer risk reduction, supplement firms say in a lawsuit filed against the agency July 16.